Chris Popple is a biopharma and clinical research executive with extensive experience in clinical development, commercialization strategy, and healthcare innovation. He currently serves as Chief Executive Officer of eLux Medical, a medical device technology company developing nanoparticle enabled solutions for aesthetic and therapeutic applications.
Over the course of his career, Chris has held leadership roles across the clinical research ecosystem, including positions with MedImmune/AstraZeneca, Wyeth and Labcorp, where he focused on expanding access to clinical trials and optimizing research delivery across healthcare systems. He later founded Nexus Collaboration Partners, a consulting organization designed to connect healthcare organizations, sponsors, and research sites through strategic partnerships and innovative collaboration models.
Chris has worked extensively on initiatives aimed at bringing clinical trials into health systems and community settings, helping to improve patient access while supporting sponsors with more efficient study execution. His experience spans decentralized clinical trials, site network strategy, and partnership development across hospitals, physician practices. He has consulted to large pharmaceutical organizations and emerging biotechnology companies.
Based in St. Thomas, he remains active in both the global clinical research industry and entrepreneurial ventures that bridge healthcare innovation with strategic collaboration.